No retraction, correction or concern found when last checked on Oct 22, 2026.
The Exposure–Response Curve for Ozone and Risk of Mortality and the Adequacy of Current Ozone Regulations
Michelle L. Bell, Roger D. Peng, Francesca Dominici
Environmental Health Perspectives · 2006 · Public domain
Abstract
Time-series analyses have shown that ozone is associated with increased risk of premature mortality, but little is known about how O3 affects health at low concentrations. A critical scientific and policy question is whether a threshold level exists below which O3 does not adversely affect mortality. We developed and applied several statistical models to data on air pollution, weather, and mortality for 98 U.S. urban communities for the period 1987–2000 to estimate the exposure–response curve for tropospheric O3 and risk of mortality and to evaluate whether a “safe” threshold level exists. Methods included a linear approach and subset, threshold, and spline models. All results indicate that any threshold would exist at very low concentrations, far below current U.S. and international regulations and nearing background levels. For example, under a scenario in which the U.S. Environmental Protection Agency’s 8-hr regulation is met every day in each community, there was still a 0.30% increase in mortality per 10-ppb increase in the average of the same and previous days’ O3 levels (95% posterior interval, 0.15–0.45%). Our findings indicate that even low levels of tropospheric O3 are associated with increased risk of premature mortality. Interventions to further reduce O3 pollution would benefit public health, even in regions that meet current regulatory standards and guidelines.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.
Tropospheric ozone is a common urban area pollutant linked to numerous harmful health effects, including reduced lung function, increased frequency of respiratory symptoms, and development of asthma. Recent meta-analysis and time-series studies have linked short-term O3 exposure to premature mortality, but the exposure–response curve for O3 remains unknown. More than 100 million people in the United States live in areas that exceed the current health-based U.S. National Ambient Air Quality Standard (NAAQS) for O3. Elevated concentrations of O3 are also a growing concern for rapidly developing nations with rising emissions of O3 precursors from expanding transportation networks.
The U.S. EPA is currently reviewing the scientific evidence on O3 and health to determine if the current NAAQS (80 ppb for the daily 8-hr maximum) should be revised to meet the goal mandated in the to protect human health with an “adequate margin of safety”. There are several critical questions regarding the association between O3 and mortality as the current NAAQS is re-examined: Can O3 affect mortality even at low levels? Are current regulations sufficiently stringent to prevent premature mortality? Is there an attainable threshold O3 level that does not affect mortality, and if so, is it below current regulatory limits? Evidence relevant to these questions can be obtained by estimating the exposure–response curve for O3 and mortality. The shape of this curve can provide a basis for a) understanding the impacts of low levels of O3 pollution on health, b) assessing the adequacy of regulatory standards, c) designing other health-based studies on O3, d) estimating the health consequences associated with emissions scenarios and policies (e.g., ), and e) assessing how climate change might affect human health through altered O3 levels (e.g., ).
Data and hierarchical model.
To investigate the exposure–response relationship between O3 and mortality, we applied several modeling structures to daily time-series data on all-cause nonaccidental mortality, weather (temperature and dew point), and O3 pollution levels for the period 1987–2000 for 98 large U.S. urban communities (Figure 1). The communities are listed in the Appendix and consist of urban areas based on a county or a set of contiguous counties. Our database includes > 40% of the total U.S. population and is part of the National Morbidity, Mortality, and Air Pollution Study (NMMAPS). We obtained air pollution data by request from the U.S. EPA, and weather data from the U.S. National Climatic Data Center.
We used measurements from ambient monitors as a surrogate for community-level exposure. The measure of exposure was the average of the same and previous days’ O3 levels (lag ). First, 24-hr averages were calculated for each day within each community, and then the lag concentrations were calculated. The use of any single day’s O3 level as the exposure metric would underestimate the relationship between O3 and mortality. We aggregated measurements from multiple monitors within a community using a 10% trimmed mean to estimate a community-level exposure.
We obtained mortality data by request from the National Center for Health Statistics. The mortality outcome is the number of daily deaths within the community excluding nonresidents and excluding those caused by injuries and other external causes corresponding to International Classification of Diseases, 9th Revision (ICD-9), codes 800 and above, and International Classification of Diseases, 10th Revision (ICD-10), codes S and above. Additional information on the generation of the air pollution data set and the entire database is available through the Internet-Based Health & Air Pollution Surveillance System (iHAPSS).
We used a Bayesian hierarchical model to evaluate the relationship between ambient O3 levels and mortality rates within each community (community-specific relative rate estimate) and to combine information across communities to produce a national average relative rate estimate, accounting for the uncertainty of each community’s relative rate. The first stage estimates the relationship between short-term exposure to O3 and daily nonaccidental mortality rates within each community, using a Poisson regression model of the form:
where μtc is the expected number of deaths for community c on day t, based on an over-dispersed Poisson distribution; xtc is the average of the same and previous days’ daily O3 concentrations in community c on day t; DOWt is the categorical variable for day of the week on day t; ns(timet,7/year) is the natural cubic spline function of calendar time with 7 degrees of freedom per year; ns(Ttc,6) is the natural cubic spline function for temperature with 6 degrees of freedom; ns(Tct−1,t −3,6) is the natural cubic spline function of the average of the 3 previous days’ temperature (adjusted for current day temperature); ns(Dtc,3) is the natural cubic spline function for dew point with 3 degrees of freedom; and ns(Dct−1,t −3,3) is the natural cubic spline function of the average of the 3 previous days’ dew point (adjusted for current day dew point). Interaction terms for age and time are the interaction terms between natural cubic spline functions of time- and age-specific indicators (< 65, 65–74, and ≥ 75 years).
In the first stage, we estimated the effect of O3 on mortality for each community,, (an estimate of the true community-specific relative rate, βc), and the corresponding variance. We assume:
where μ is the true national average relative rate and τ2 is the variance of the true community-specific relative rates, βc. Sensitivity analyses and characteristics of the first-stage statistical model for confounding adjustment have been explored for particulate matter (PM), with results indicating that national average estimates are robust to model specification for weather and seasonal confounding. Earlier analysis showed national-average and community-specific estimates for O3 and mortality to be robust to inclusion of PM10 (PM with an aerodynamic diameter < 10 μm) in the first-stage model. Results were also robust to exclusion of days with high temperature.
As a second stage, we generated a national relative rate estimate that accounts for the statistical uncertainty of each community’s relative rate estimate and for the variability across communities of the true relative rates. We fit this two-stage normal–normal model by use of a two-level normal independent sampling estimation with noninformative priors.
Using this two-stage approach, we performed four analyses that make different modeling assumptions about the community-specific exposure–response curve for O3 and mortality. Under each analysis, we estimated a national relative rate and/or a national exposure–response curve by combining information across the 98 communities.
Linear approach.
For the first analysis, the linear approach, we estimated a linear association between the log of the expected mortality rate and O3 levels as described in Equation 1. This model assumes that any change in O3 concentration, even at very low levels, can be associated with mortality. For example, a 10-ppb increase in O3 levels from 5 to 15 ppb would lead to the same percentage increase in mortality as a 10-ppb rise from 50 to 60 ppb. This is the modeling approach used in most epidemiologic studies of air pollution and in most health and impact assessments of air pollution policies. We then relaxed this assumption of linearity across the entire range of O3 levels with the three approaches described below.
Subset approach.
Under the second analysis, the subset approach, we estimated a linear relationship between the log of the expected mortality rate and O3 levels as in Equation 1 but using a subset of the data including only days with lag O3 levels below a specified concentration, s. We performed this analysis for values of s ranging from 5 to 60 ppb. Under this approach, we assume that “safe” O3 levels are those lower than the specific s value that leads to lack of evidence of an association between O3 and mortality.
We also used the subset approach to assess the relationship between O3 and mortality under several idealized policy scenarios in which various O3 regulations and guidelines were met every day in each community. Because O3 regulations are expressed in different metrics, we proceeded in three steps. First, we used hourly O3 concentrations to calculate daily O3 levels under the same metric specified by the standard (e.g., daily 8-hr maximum or daily 1-hr maximum). Second, we constructed a subset of the data set that includes only days that meet the regulatory standard or guideline. For example, for the U.S. EPA O3 standard, we first calculated a daily time series of 8-hr maximum O3 levels, and then we constructed a subset of the data set that only includes days with an 8-hr maximum O3 level < 84 ppb. Third, using only days that met the standard, we estimated the percentage increase in mortality associated with a 10-ppb increase in lag O3 levels on average across the 98 communities, with the 95% posterior interval, which is the Bayesian analogue of the 95% confidence interval. This strategy allows us to analyze the subset of days that meet a regulatory requirement using the metric specified in the standard but to present results with a single metric for the exposure variable (lag of the 24-hr averages) to maintain a common interpretation of the relative rate estimates.
The NAAQS for O3 is “80 ppb” for the daily 8-hr maximum, but U.S. EPA regulations specify that values between 80 and 84 ppb can be rounded down and are not considered exceedances. Thus, for our analysis of the NAAQS, we considered a standard of 84 ppb for the daily 8-hr maximum. Regulations generally do not require every monitor to meet the standard every day. For example, a standard can allow a specified number of exceedances and require that a certain percentile (e.g., 98th) meet the requirement on a 3-year average. In actual compliance with a regulatory standard for a given area, the levels of pollution would follow an uneven spatial distribution. Our analysis considers a more stringent application in that it incorporates only days with O3 levels at or below the specific standard for both the same and previous days. However, the regulatory standard requires compliance from every monitor, whereas this analysis considers averages across communities rather than individual monitor exceedances.
Threshold approach.
If a threshold (h) exists, we would expect to detect an association between O3 and mortality for O3 levels > h but not for O3 levels < h. Our threshold approach has the same structure of Equation 1, but with the pollution term replaced by
where
Under this model, we assume no association between O3 and mortality for days with O3 concentrations below h and a linear relationship for days with O3 levels above h. We performed this analysis for values of h ranging from 0 to 60 ppb at increments of 5 ppb. For each community-specific model and threshold level (h), we calculated the Akaike Information Criterion (AIC) as
Note that the number of parameters can differ by urban community because of the varying frequencies with which O3 is measured and the variables for time. We then calculated the average AIC for each h value as
where n = number of communities (98). The rationale for this approach is that if an O3 threshold exists, the threshold approach with the appropriate value for h will have the best fit and therefore the minimum (h).
Spline approach.
Under the fourth analysis, the spline approach, we allow the relationship between O3 and mortality to fluctuate for different ranges of pollution levels, using a nonlinear function of O3. This model can be defined as Equation 1 but replacing βcxtc with ns(xtc), where ns is a natural cubic spline of O3 levels. Boundary knots were specified at 0 and 80 ppb, with interior knots at 20 and 40 ppb. The spline approach extends the linear approach because here the relative rate corresponding to a 10-ppb increase in O3 levels from 5 to 15 ppb is allowed to differ from the relative rate corresponding to a 10-ppb increase from 50 to 60 ppb. Visual inspection of the estimated exposure–response curve can provide evidence about whether a safe level exists and at what concentration.
Results
We found that daily increases in ambient O3 levels were significantly associated with daily increases in the number of deaths, on average, across the 98 U.S. communities. Specifically, under the linear approach, we found that the percentage increase in all-cause mortality associated with a 10-ppb increase in the lag O3 levels was 0.32% (95% posterior interval, 0.17–0.46%). We also found that the largest relative rate estimates occur on more recent days: the percentage increases (95% posterior intervals) in all-cause mortality associated with a 10-ppb increase in lag daily O3 levels were 0.25% (0.12 to 0.38%), 0.18% (0.07 to 0.30%), 0.14% (0.03 to 0.26%), and 0.04% (–0.07 to 0.16%) for single-day lags of 0, 1, 2, and 3 days, respectively. The community-specific maximum likelihood estimates under the linear approach displayed no association with the communities’ long-term O3 concentrations over the study period, as tested by correlation and weighted second-stage regression.
Our results show that daily increases in ambient O3 were significantly associated with daily increases in the number of deaths, on average, across the 98 U.S. communities for the idealized policy scenarios under which every community meets current O3 regulatory standards and guidelines for every day of the study period, 1987–2000 (Table 1). For example, the percentage increase in all-cause mortality associated with a 10-ppb increase in lag O3 levels was 0.30% (0.15–0.45%) when we used a data set including only days with a daily 8-hr maximum O3 concentration lower than U.S. O3 regulations. We also found that daily increases in ambient O3 exposure are linked to premature mortality under compliance with other O3 regulations, including some more stringent than the U.S. standards. In summary, these results indicate that current regulations, even California’s new, more stringent standards, are not sufficiently low to provide complete protection against the risk of premature mortality from O3.
Daily changes in ambient O3 were significantly associated with daily changes in the number of deaths, on average, across the 98 U.S. communities, even when we used data that include only days with lag average O3 levels < 15 ppb. Figure 2 shows the estimated percentage increase in mortality for a 10-ppb increase in the lag O3 level for different values of s. National relative rate estimates for s values ranging from 35 to 60 ppb are similar to the ones obtained by using all data. The 95% posterior interval increases as s is lowered because of the decreasing sample size. For example, at an s value of 40 ppb, 30% of days are excluded from analysis, on average, across the 98 communities. At an s of 20 ppb, 73% of days are excluded. The estimates decline and lose significance only when s is equal to very low concentrations (≤ 10 ppb). Therefore, the subset approach suggests that a “safe” O3 level would be lower than approximately 10 ppb, for the lag daily O3 level, which is roughly 15–19 ppb for the maximum 8-hr average. However, relative rate estimates for s ≤ 10 ppb have large statistical uncertainty because of the very small number of days with O3 concentrations so low. In fact, 73 communities were excluded entirely at an s of 5 ppb because of insufficient data.
Results from the threshold and spline approaches are consistent with those from the subset approach and provide evidence that a “safe” O3 level can only exist at very low concentrations. We found that the model fit under the threshold approach for values of h from 5 to 60 ppb never provides more than a nominal improvement (< 1% difference in the ) over the model fit under the linear approach (analogous to the threshold approach with h = 0) for the national average and each individual community. In other words, a model that allows for a “safe” O3 level fit the data only marginally better than a model that assumes any level of O3 pollution, even low concentrations, can be associated with mortality. The spline approach indicates that the national average exposure–response curve obtained using natural cubic splines is near horizontal, indicating the lack of evidence for an association, only at the very low concentrations (from 0 to ~10 ppb) and then becomes approximately linear at higher concentrations (Figure 3).
Discussion
In summary, our nationwide study provides strong and consistent evidence that daily changes in ambient O3 exposure are linked to premature mortality, even at very low pollution levels, including an idealized scenario of complete adherence to current O3 regulations. We also found robust evidence of this relationship between O3 exposure and mortality when we used data that included only O3 levels nearing background concentrations, which typically range from 10 to 25 ppb. Therefore, any anthropogenic contribution to ambient O3, however slight, still presents an increased risk for premature mortality.
Results from this multisite national study are consistent with single-site time-series studies that found no evidence of a “safe” O3 leve at concentrations higher than background levels. Consistent with the results obtained under our spline approach, found that a spline model indicated a threshold around 20–30 ppb for the daily 1-hr maximum, which is approximately equal to 8–12 ppb for the 24-hr average, using 5 years of data for Seoul, Korea. found that relative risk estimates of mortality associated with daily changes in O3 were robust to exclusion of days with a 24-hr average ≥ 40 μg/m3 (about 20 ppb) in a study of Rotterdam, the Netherlands, and concluded that should a threshold exist, it may be at a low concentration. Adverse health responses such as decreases in pulmonary function, alterations in the respiratory tract, and declines in lung function have been observed at O3 levels close to background concentrations. O3 levels below U.S. EPA regulations have been associated with increased frequency of respiratory symptoms in children with asthma.
Pollution levels below air quality regulatory standards should not be misinterpreted as safe for human health. For instance, the San Joaquin Valley Air Pollution Control District refers to the standards as the “highest level of O3 that can be present without adverse health effects”. However, decision makers and the public should distinguish between the complete absence of harm and a lessened or acceptable risk. In fact, the interpretation of an “adequate margin of safety” and what is a “safe” level could depend on the individual, because people may differ in their susceptibility to air pollutants, and could depend on the evolving knowledge about the health impacts of air pollution at low levels. This research shows that any reduction in ambient O3 levels, such as through transportation planning in urban areas, should yield important benefits to public health, even in areas that meet current regulatory standards. Persons may be adversely affected by O3 pollution, even at very low levels including days that meet current regulatory requirements.
References 44
- 1.
Akaike H 1973. Information theory and extension of the maximum likelihood principle. In: International Symposium on Information Theory (Petrov BN, Caski F, eds). Budapest: Akademiai Kaiado, 267–281.
Not in our library
- 2.
What constitutes an adverse health effect of air pollution? Am J Respir Crit Care Med. 2000;161:665-673.
Not in our library10.1164/ajrccm.161.2.ats4-00
- 3.
Anderson HR Atkinson RW Peacock JL Marston L Konstantinou K 2004. Meta-Analysis of Time-Series Studies and Panel Studies of Particulate Matter (PM) and Ozone (O3). Report of a WHO Task Group. Copenhagen:World Health Organization.
Not in our library
- 4.
Bell ML, Dominici F, Samet JM. A meta-analysis of time-series studies of ozone and mortality with comparison to the National Morbidity, Mortality, and Air Pollution Study. Epidemiology. 2005;4:436-445.
Not in our library10.1097/01.ede.0000165817.40152.85
- 5.
Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987–2000. JAMA. 2004;292:2372-2378.
Not in our library10.1001/jama.292.19.2372
- 6.
Broeckaert F, Arsalane K, Hermans C, Bergamaschi E, Brustolin A, Mutti A, et al. Lung epithelial damage at low concentrations of ambient ozone. Lancet. 1999;353:900-901.
Not in our library10.1016/s0140-6736(99)00540-1
- 7.
Brunekreef B, Holgate ST. Air pollution and health. Lancet. 2002;360:1233-1242.
Not in our library10.1016/s0140-6736(02)11274-8
- 8.
California Environmental Protection Agency 2005. California Adopts New Ozone Standard. Sacramento:California Air Resources Board.
Not in our library
- 9.
Canadian Council of Ministers of the Environment 2000. Canada-wide standards for particulate matter (PM) and ozone. Quebec City:Canadian Council of Ministers of the Environment.
Not in our library
- 10.
Chan CC, Wu TH. Effects of ambient ozone exposure on mail carriers’ peak expiratory flow rates. Environ Health Perspect. 2005;113:735-738.
Not in our library10.1289/ehp.7636
- 11.
Clean Air Act Amendments of 1990 1990. Public Law 101-549.
Not in our library
- 12.
Daniels MJ, Dominici F, Samet JM, Zeger SL. Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. Am J Epidemiol. 2000;152:397-406.
Not in our library10.1093/aje/152.5.397
- 13.
Daniels MJ Dominici F Zeger SL Samet JM 2004. The National Morbidity, Mortality, and Air Pollution Study Part III: PM10 Concentration-Response Curves and Thresholds for the 20 Largest US cities. Report 94, pt 3. Cambridge, MA:Health Effects Institute.
Not in our library
- 14.
Dominici F, Daniels M, Zeger SL, Samet JM. Air pollution and mortality: estimating regional and national dose-response relationships. J Am Stat Assoc. 2002;97:100-111.
Not in our library
- 15.
Dominici F, Samet JM, Zeger SL. Combining evidence on air pollution and daily mortality from the largest 20 US cities: a hierarchical modeling strategy. J R Stat Soc A. 2000;163:263-302.
Not in our library
- 16.
European Commission 2002. Directive 2002/3/EC of the European Parliament and of the Council. Directive 2002/3/EC. Brussels, Belgium:European Commission.
Not in our library
- 17.
Everson PJ, Morris CN. Inference for multivariate normal hierarchical models. J R Stat Soc B. 2000;62:399-412.
Not in our library
- 18.
Fiore A Jacob DJ Liu H Yantosca RM Fairlie TD Li Q. 2003. Variability in surface ozone background over the United States implications for air quality policy. J Geophys Res Atmos. 10.1029/2003JD003855.
Not in our library
- 19.
Fiore A Jacob D J Liu H Yantosca RM Fairlie TD Li Q. 2004. Correction to “Variability in surface ozone background over the United States implications for air quality policy.” J Geophys Res Atmos. 10.1029/2004JD004567.
Not in our library
- 20.
Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS, et al. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA. 2003;290:1859-1867.
Not in our library10.1001/jama.290.14.1859
- 21.
Hoek G, Schwartz JD, Groot B, Eilers P. Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, the Netherlands. Arch Environ Health. 1997;52:455-463.
Not in our library10.1080/00039899709602224
- 22.
Huang Y, Dominici F, Bell ML. Bayesian hierarchical distributed lag models for summer ozone exposure and cardio-respiratory mortality. Environmetrics. 2005;16:547-562.
Not in our library10.1002/env.721
- 23.
Hubbell BJ, Hallberg A, McCubbin DR, Post E. Health-related benefits of attaining the 8-hr ozone standard. Environ Health Perspect. 2005;113:73-82.
Not in our library10.1289/ehp.7186
- 24.
iHAPSS 2006. Internet-Based Health & Air Pollution Surveillance System. Baltimore, MD:Johns Hopkins Bloomberg School of Public Health. Available: http://www.ihapss.jhsph.edu/ [accessed 5 January 2006].
Not in our library
- 25.
Ito K, De Leon SF, Lippmann M. Associations between ozone and daily mortality: analysis and meta-analysis. Epidemiology. 2005;4:446-457.
Not in our library10.1097/01.ede.0000165821.90114.7f
- 26.
Kim SY, Lee JT, Hong YC, Ahn KJ, Kim H. Determining the threshold effect of ozone on daily mortality: an analysis of ozone and mortality in Seoul, Korea, 1995–1999. Environ Res. 2004;94:113-119.
Not in our library10.1016/j.envres.2003.09.006
- 27.
Knowlton K, Rosenthal JE, Hogrefe C, Lynn B, Gaffin S, Goldberg R, et al. Assessing ozone-related health impacts under a changing climate. Environ Health Perspect. 2004;112:1557-1563.
Not in our library10.1289/ehp.7163
- 28.
Levy JI, Chemerynski SM, Sarnat JA. Ozone exposure and mortality: an empiric Bayes metaregression analysis. Epidemiology. 2005;4:458-468.
Not in our library10.1097/01.ede.0000165820.08301.b3
- 29.
McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman WJ, et al. Asthma in exercising children exposed to ozone: a cohort study. Lancet. 2002;359:386-391.
Not in our library10.1016/s0140-6736(02)07597-9
- 30.
McCullagh P Nelder JA 1989. Generalized Linear Models. 2nd ed. London:Chapman & Hall/CRC.
Not in our library
- 31.
Peng RD, Dominici F, Pastor-Barriuso R, Zeger SL, Samet JM. Seasonal analyses of air pollution and mortality in 100 US cities. Am J Epidemiol. 2005;161:585-594.
Not in our library10.1093/aje/kwi075
- 32.
Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987–1994. N Engl J Med. 2000a;343:1742-1749.
Not in our library10.1056/nejm200012143432401
- 33.
Samet JM Dominici F Zeger SL Schwartz J Dockery DW 2000b. The National Morbidity, Mortality, and Air Pollution Study Part I: Methods and Methodologic Issues. Report 94, pt 1. Cambridge, MA:Health Effects Institute.
Not in our library
- 34.
Samet JM Zeger SL Dominici F Curriero F Coursac I Dockery DW et al. 2000c. The National Morbidity, Mortality, and Air Pollution Study Part II: Morbidity and Mortality from Air Pollution in the United States. Report 94, pt 2. Cambridge, MA:Health Effects Institute.
Not in our library
- 35.
San Joaquin Valley Air Pollution Control District 2006. Ozone. Fresno, CA:San Joaquin Valley Air Pollution Control District. Available: http://www.valleyair.org/Air_Quality_Plans/AQ_plans_Ozone_standards.htm [accessed 5 January 2006].
Not in our library
- 36.
TLNise 2006. Two Level Normal Independent Sampling Estimation. Swarthmore, PA:Swarthmore College. Available: http://www.swarthmore.edu/NatSci/peverso1/TLNise/tlnise.htm [accessed 5 January 2006].
Not in our library
- 37.
U.S. EPA 1996. Air Quality Criteria for Ozone and Related Photochemical Oxidants. EPA/600/P-93/004a-cF. Washington, DC:U.S. Environmental Protection Agency.
Not in our library
- 38.
U.S. EPA. National ambient air quality standards for ozone. Fed Reg. 1997;62:38855-38896.
Not in our library
- 39.
U.S. EPA 2004. The Ozone Report: Measuring Progress through 2003. EPA/454/K-04–001. Research Triangle Park, NC:U.S. Environmental Protection Agency.
Not in our library
- 40.
U.S. EPA 2005. Review of the National Ambient Air Quality Standards for Particulate Matter: Policy Assessment of Scientific and Technical Information. EPA-452/R-05/005. Research Triangle Park, NC:U.S. Environmental Protection Agency.
Not in our library
- 41.
Welty LJ, Zeger SL. Are the acute effects of particulate matter on mortality in the National Morbidity, Mortality, and Air Pollution Study the result of inadequate control for weather and season? A sensitivity analysis using flexible distributed lag models. Am J Epidemiol. 2005;162:80-88.
Not in our library10.1093/aje/kwi157
- 42.
WHO 1978. International Classification of Diseases, 9th Revision. Geneva:World Health Organization.
Not in our library
- 43.
WHO 1993. International Classification of Diseases, 10th Revision. Geneva:World Health Organization.
Not in our library
- 44.
WHO 2000. Air Quality Guidelines for Europe. 2nd ed. WHO Regional Publications, European Series, no. 91. Copenhagen:World Health Organization Regional Office for Europe.
Not in our library
Cited by papers we hold 6
- Ambient air pollution and cause-specific risk of hospital admission in China: A nationwide time-series study · 2020No notice
- Short term association between ozone and mortality: global two stage time series study in 406 locations in 20 countries · 2020No notice
- Ozone Pollution: A Major Health Hazard Worldwide · 2019No notice
- CLIMATE CHANGE EFFECTS ON URBAN LEVEL: CITIZEN HEALTH AND BUILDING ENERGY DEMAND · 2017Not checked
- Healthy Neighborhoods: Walkability and Air Pollution · 2009No notice
- Ozone’s Impact on Public Health: Contributions from Indoor Exposures to Ozone and Products of Ozone-Initiated Chemistry · 2006No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.